Find a Doctor

Dr. Richard Sanford Finkel

Nemours Children's Hospital
Pediatrics, Neurology, Addiction Medicine

Bio


Richard Finkel is a Pediatrics specialist and a Neurologist in Memphis, Tennessee. Dr. Finkel is a global expert in Spinal Muscular Atrophy Type 3. He has been an author on 158 peer reviewed articles and participated in 5 clinical trials in the past 15 years. In particular, he has been an author on 37 peer reviewed articles regarding Spinal Muscular Atrophy Type 3. Dr. Finkel's top three areas of expertise are Spinal Muscular Atrophy, Primary Lateral Sclerosis, Muscle Atrophy, and Spinal Muscular Atrophy Type 1. He is licensed to treat patients in PA, FL, and TN.

Contact

262 Danny Thomas Pl
Memphis, TN 38105, US

Latest Advances


  • Condition: Duchenne Muscular Dystrophy
  • Journal: PLoS medicine
  • Treatment Used: Vamorolone
  • Number of Patients: 23
  • Published —
This study tested the safety and efficacy of using vamorolone to treat patients with Duchenne muscular dystrophy.
  • Condition: Duchenne muscular dystrophy
  • Journal: Neurology
  • Treatment Used: Vamorolone
  • Number of Patients: 48
  • Published —
The study aimed to research the use of vamorolone for duchenne muscular dystrophy.
  • Condition: Later-Onset Spinal Muscular Atrophy
  • Journal: Muscle & nerve
  • Treatment Used: Nusinersen
  • Number of Patients: 14
  • Published —
This study analyzed the effectiveness of Nusinersen to treat patients with spinal muscular atrophy (SMA; rare neuromuscular disorder).
  • Condition: Duchenne Muscular Dystrophy in Pediatric Children
  • Journal: Journal of neuromuscular diseases
  • Treatment Used: Edasalonexent
  • Number of Patients: 17
  • Published —
The study researched the effects of Edasalonexent in treating Duchenne muscular dystrophy in pediatric children.
  • Condition: Duchenne muscular dystrophy
  • Journal: Pharmacological research
  • Treatment Used: Vamarolone
  • Number of Patients: 0
  • Published —
This study evaluated the safety and efficacy of vamorolone in patients with Duchenne muscular dystrophy.

Clinical Trials


Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 152
  • Start Date: March 26, 2020
Escalating Dose and Randomized, Controlled Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy
Clinical Trial
  • Status: Recruiting
  • Participants: 1050
  • Start Date: May 2010
Genetics of Charcot Marie Tooth Disease (CMT) - Modifiers of CMT1A, New Causes of CMT
Clinical Trial
  • Status: Recruiting
  • Participants: 500
  • Start Date: April 2010
Development and Validation of CMT Pediatric Scale for Children With Charcot Marie Tooth

Contact

262 Danny Thomas Pl
Memphis, TN 38105, US

Credentials

  • Licenses
    Pediatrics in PA

Insurance

Contact them to find out if they accept your insurance plan.